| Schedule of Reconciliation of Consolidated Segment |
| For the three months ended March 31, 2026 | |
Technology | | |
Telehealth | | |
Total | |
| | |
| | |
| | |
| |
| Revenues: | |
| | |
| | |
| |
| Subscription fees | |
$ | 605,470 | | |
$ | - | | |
$ | 605,470 | |
| Professional services and other fees | |
| 580,981 | | |
| - | | |
| 580,981 | |
| Technical engineering fees | |
| 94,441 | | |
| - | | |
| 94,441 | |
| Patient fees | |
| - | | |
| 881,340 | | |
| 881,340 | |
| Telehealth fees | |
| - | | |
| 997,953 | | |
| 997,953 | |
| Total revenues | |
$ | 1,280,892 | | |
$ | 1,879,293 | | |
$ | 3,160,185 | |
| | |
| | | |
| | | |
| | |
| Cost of revenues | |
| 810,193 | | |
| 1,151,881 | | |
| 1,962,074 | |
| Segment gross margin | |
$ | 470,699 | | |
$ | 727,412 | | |
$ | 1,198,111 | |
| | |
| | | |
| | | |
| | |
| Less (1): | |
| | | |
| | | |
| | |
| Compensation and related benefits | |
| 1,482,984 | | |
| 275,091 | | |
| 1,758,075 | |
| General and administrative | |
| 302,457 | | |
| 1,237,382 | | |
| 1,539,839 | |
| | |
| | | |
| | | |
| | |
| Segment operating loss | |
$ | (1,314,742 | ) | |
$ | (785,061 | ) | |
$ | (2,099,803 | ) |
| | |
| | | |
| | | |
| | |
| Reconciliation to loss before income taxes: | |
| | | |
| | | |
| | |
| Unallocated corporate overhead expenses | |
| | | |
| | | |
| (874,472 | ) |
| Interest expense | |
| | | |
| | | |
| (113,098 | ) |
| Change in fair value of financial instruments | |
| | | |
| | | |
| 143,040 | |
| Gain on extinguishment of financial liabilities | |
| | | |
| | | |
| 367,809 | |
| Loss before provision for income taxes | |
| | | |
| | | |
$ | (2,576,524 | ) |
| (1) | The
significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. |
| For the three months ended March 31, 2025 | |
Technology | | |
Telehealth | | |
Total | |
| | |
| | |
| | |
| |
| Revenues: | |
| | |
| | |
| |
| Subscription fees | |
$ | 827,345 | | |
$ | - | | |
$ | 827,345 | |
| Professional services and other fees | |
| 896,680 | | |
| - | | |
| 896,680 | |
| Technical engineering fees | |
| 399,846 | | |
| - | | |
| 399,846 | |
| Patient fees | |
| - | | |
| 711,264 | | |
| 711,264 | |
| Telehealth fees | |
| - | | |
| 483,850 | | |
| 483,850 | |
| Institutional fees | |
| - | | |
| 2,500 | | |
| 2,500 | |
| Total revenues | |
$ | 2,123,871 | | |
$ | 1,197,614 | | |
$ | 3,321,485 | |
| | |
| | | |
| | | |
| | |
| Cost of revenues | |
| 1,074,124 | | |
| 387,390 | | |
| 1,461,514 | |
| Segment gross margin | |
$ | 1,049,747 | | |
$ | 810,224 | | |
$ | 1,859,971 | |
| | |
| | | |
| | | |
| | |
| Less (1): | |
| | | |
| | | |
| | |
| Compensation and related benefits | |
| 1,164,051 | | |
| 412,319 | | |
| 1,576,370 | |
| General and administrative | |
| 239,933 | | |
| 981,079 | | |
| 1,221,012 | |
| Segment operating loss | |
$ | (354,237 | ) | |
$ | (583,174 | ) | |
$ | (937,411 | ) |
| | |
| | | |
| | | |
| | |
| Reconciliation to loss before income taxes: | |
| | | |
| | | |
| | |
| Unallocated corporate overhead expenses | |
| | | |
| | | |
| (893,907 | ) |
| Interest expense | |
| | | |
| | | |
| (730,665 | ) |
| Other income, net | |
| | | |
| | | |
| 15,539 | |
| Change in fair value of financial instruments | |
| | | |
| | | |
| (1,261,471 | ) |
| Loss on issuance of financial instruments | |
| | | |
| | | |
| (138,020 | ) |
| Loss before provision for income taxes | |
| | | |
| | | |
$ | (3,945,935 | ) |
| (1) | The
significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. |
|
| Schedule of Total Assets by Segment |
| | |
March 31,
2026 | | |
December 31,
2025 | |
| Total assets: | |
| | |
| |
| Technology | |
$ | 605,513 | | |
$ | 664,525 | |
| Telehealth | |
| 16,656,643 | | |
| 17,150,543 | |
| Non-operating corporate | |
| 1,754,263 | | |
| 4,597,951 | |
| Total | |
$ | 19,016,419 | | |
$ | 22,413,019 | |
| | |
March 31, 2026 | | |
December 31, 2025 | |
| Total Goodwill: | |
| | |
| |
| Technology | |
$ | - | | |
$ | - | |
| Telehealth | |
| 4,916,694 | | |
| 4,916,694 | |
| Non-operating corporate | |
| - | | |
| - | |
| Total | |
$ | 4,916,694 | | |
$ | 4,916,694 | |
|
| Schedule of Reportable Segment Depreciation and Amortization and Capital Expenditures |
| | |
March 31, 2026 | | |
March 31, 2025 | |
| Depreciation and Amortization: | |
| | |
| |
| Technology | |
$ | 4,227 | | |
$ | 2,161 | |
| Telehealth | |
| 642,392 | | |
| 644,876 | |
| Total | |
$ | 646,619 | | |
$ | 647,037 | |
| | |
March 31, 2026 | | |
March 31, 2025 | |
| Capital Expenditures: | |
| | |
| |
| Technology | |
$ | 26,752 | | |
$ | 11,873 | |
| Telehealth | |
| - | | |
| - | |
| Total | |
$ | 26,752 | | |
$ | 11,873 | |
| | |
March 31, 2026 | | |
March 31, 2025 | |
| Interest Expense: | |
| | |
| |
| Technology | |
$ | 21,155 | | |
$ | 21,158 | |
| Telehealth | |
| 20,642 | | |
| 54,252 | |
| Non-operating corporate | |
| 71,301 | | |
| 655,255 | |
| Total | |
$ | 113,098 | | |
$ | 730,665 | |
|